Tonix Pharmaceuticals Holding Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TNXP research report →
About the company
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort.
- CEO
- Seth Lederman
- IPO
- 2012
- Employees
- 81
- HQ
- Chatham, NJ, US
Price Chart
- Market Cap
- $196.71M
- P/E
- -0.84
- P/S
- 11.20
- P/B
- 0.74
- EV/EBITDA
- -0.09
- Div Yield
- 0.00%
- Gross Margin
- 52.62%
- Op Margin
- -861.16%
- Net Margin
- -839.52%
- ROE
- -67.65%
- ROIC
- -66.19%
- Revenue
- $13.11M · 29.85%
- Net Income
- $-124,021,000 · 4.63%
- EPS
- $-14.57 · 91.75%
- Op Income
- $-125,703,000
- FCF YoY
- -69.08%
- 52W High
- $69.97
- 52W Low
- $10.03
- 50D MA
- $12.71
- 200D MA
- $16.13
- Beta
- 1.68
- Avg Volume
- 485.64K
Get TickerSpark's AI analysis on TNXP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 12, 26 | Taylor Carolyn E. | buy | 1,415 |
| Jun 8, 26 | Stillwell Richard Newcomb | buy | 5,000 |
| Jun 9, 26 | LEDERMAN SETH | buy | 5,000 |
| May 12, 26 | Stillwell Richard Newcomb | other | 22,700 |
| May 12, 26 | OLUKOTUN ADEOYE Y | other | 22,700 |
| May 12, 26 | Bell Margaret Smith | other | 22,700 |
| May 12, 26 | Hunter James Randolph Jr | other | 22,700 |
| May 12, 26 | Treco James | other | 22,700 |
| May 12, 26 | GRANGE DAVID L | other | 22,700 |
| May 12, 26 | BAGGER RICHARD H | other | 22,700 |
Our TNXP coverage
Recent articles, reports, and earnings notes.
No research on TNXP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TNXP report →Similar companies
Peers in the same neighborhood.